David R. Linz, MD, FACP, Internal Medicine, Moorings Park. During its EHR system transition, NCH collaborated with FDB to tailor medication alerts specifically to patient contexts. This focus on “patient-first” medication decision support resulted in a marked reduction in frequently dismissed alerts for conditions such as hyperkalemia, QT prolongation, opioid use in outpatient settings, and nephrotoxicity, thereby ensuring a higher level of clinical relevance and patient safety. The outcomes? Drug-drug interaction (DDI) alerts dropped by up to 37.5% and targeted DDI alerts for high-volume medications shrinking by up to 94%. Furthermore, the initiative boasted a 25% reduction in overall CDS alerts per order in its first phase and has also contributed to NCH’s improvement in its Leapfrog CPOE test results.
Sponsored by Hearst | First Databank
Presentations and recordings of this event are available only to members. Log In or create a profile.